Catalyst Event
3SBio Inc (1530) · Other
From Akros SCHK HK-Global Brain-Computer Interface Index (ASHGBCI)
5/26/2026, 12:00:00 AM
On May 26, 2026, 3SBio announced a proposal to appoint KPMG as its new auditor, replacing Ernst & Young, subject to shareholder approval at the upcoming Annual General Meeting (estimated ≥1% impact as auditor change is a routine corporate matter).
Korean Translation
2026년 5월 26일, 다가오는 주주총회에서 주주들의 승인을 조건으로 언스트앤영을 대신하여 KPMG를 새로운 감사인으로 선임할 것을 제안함 (감사인 변경은 통상적인 행정 절차로 1% 이상의 주가 영향 예상됨).
Related Recent Events
Eli Lilly and Co (LLY) · Earnings Release
Q2 2026 earnings release and conference call. Medium importance is estimated as earnings releases typically cause >5% price volatility scheduled.
8/5/2026, 12:00:00 AM
Boston Scientific Corp (BSX) · Earnings Release
The Q2 2026 earnings release scheduled for 2026-07-29, for which high importance is estimated due to typical market volatility surrounding quarterly results, is expected.
7/29/2026, 12:00:00 AM
Abbott Laboratories (ABT) · Earnings Release
Q2 2026 earnings release is scheduled for July 16, 2026; a price impact of at least 5% is estimated based on historical volatility, scheduled.
7/16/2026, 12:00:00 AM
Hansoh Pharmaceutical Group Company Limited (3692) · Other
Final dividend of HKD 0.20 per share ex-dividend on July 3, 2026; standard corporate action with minor price adjustment scheduled.
7/3/2026, 12:00:00 AM
CSPC Pharmaceutical Group Ltd (1093) · Other
Ex-dividend date for the 2025 final dividend of HK$0.15 per share, which was announced on March 25, 2026. The payment date is July 15, 2026.
6/24/2026, 12:00:00 AM
Sonova Holding AG (SOON) · Other
Ex-dividend date (2026-06-19) for a proposed record-high annual dividend of CHF 4.70 per share; impact estimated at ~2% as dividend is record-high, scheduled.
6/19/2026, 12:00:00 AM